(Q84582216)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21777821%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

title

CSF α-synuclein, tau, and amyloid β in Parkinson's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21777821%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference

Min Shi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21777821%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Jing Zhang

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21777821%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

publication date

1 August 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21777821%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21777821%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21777821%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21777821%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

page(s)

681; author's reply 681-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21777821%20AND%20SRC:MED&resulttype=core&format=json

α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study

8 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970130-2

7 January 2021

Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970130-2

7 January 2021

DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970130-2

7 January 2021

CSF Aβ(42) and tau in Parkinson's disease with cognitive impairment.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970130-2

7 January 2021

CSF neurofilament light chain and tau differentiate multiple system atrophy from Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970130-2

7 January 2021

CSF amyloid-beta and tau proteins, and cognitive performance, in early and untreated Parkinson's disease: the Norwegian ParkWest study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970130-2

7 January 2021

Genome-wide association study reveals genetic risk underlying Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970130-2

7 January 2021

Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970130-2

7 January 2021

Synergistic Interactions between Abeta, tau, and alpha-synuclein: acceleration of neuropathology and cognitive decline

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970130-2

7 January 2021

Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer's and Parkinson's diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970130-2

7 January 2021

10.1016/S1474-4422(11)70130-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21777821%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference